Effect of SCY-078 on the Pharmacokinetics of CYP2C8 substrate (Rosiglitazone) - Results from a Phase 1 Clinical Trial
D. Angulo, G. Atiee, C. Corr, M. Willett, G. Murphy, S. Wring
27th European Congress of Clinical Microbiology and Infectious Diseases
April 2017